Affiliation:
1. Department of Radiation Oncology Eye & ENT Hospital Fudan University Shanghai China
Abstract
AbstractSinonasal teratocarcinosarcoma (SNTCS) is a rare malignancy characterized by a highly aggressive nature. It mainly arises in the ethmoidal or maxillary sinus. SNTCS has a poor prognosis, with a mean survival rate of 55% at 2 years. Herein, we presented a case of advanced SNTCS successfully treated with surgery followed by chemoradiotherapy plus targeted therapy and reviewed the published literature on this rare entity.
Reference14 articles.
1. Sinonasal teratocarcinosarcoma: a therapeutic dilemma
2. Treatment of Sinonasal Teratocarcinosarcoma: A Systematic Review and Survival Analysis
3. Sinonasal teratocarcinosarcoma-A case report
4. Teratocarcinoma sarcoma of nasal cavity and paranasal sinuses: a case report;Qu YC;Chin J CT and MRI,2015
5. A case of paranasal sinus teratocarcinoma sarcoma involving the left frontal lobe;Shi YY;Chin J Interv Imaging Ther,2018